Cargando…
Chemoprevention of colorectal cancer: Past, present, and future
Chemoprevention began to be considered as a potential strategy for lowering the incidence of cancer and cancer‐related deaths in the 1970s. For clinical chemoprevention trials against cancer, including colorectal cancer (CRC), well‐established biomarkers are necessary for use as reliable endpoints....
Autores principales: | Umezawa, Shotaro, Higurashi, Takuma, Komiya, Yasuhiko, Arimoto, Jun, Horita, Nobuyuki, Kaneko, Takeshi, Iwasaki, Motoki, Nakagama, Hitoshi, Nakajima, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778640/ https://www.ncbi.nlm.nih.gov/pubmed/31361372 http://dx.doi.org/10.1111/cas.14149 |
Ejemplares similares
-
Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity
por: Komiya, Yasuhiko, et al.
Publicado: (2019) -
Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis
por: Arimoto, Jun, et al.
Publicado: (2016) -
Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018) -
PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study
por: Takahashi, Hirokazu, et al.
Publicado: (2010) -
Chemoprevention in familial adenomatous polyposis: past, present and future
por: Kemp Bohan, Phillip M., et al.
Publicado: (2020)